OMIC - Singular Genomics Systems - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Singular Genomics Systems's activity chart (see below) currently has 27 price targets and 24 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 33.63% of the time, taking 23.25 days on average.

Most recent stock forecast was given by MATTHEW SYKES from on 08-Jul-2024. First documented stock forecast 21-Jun-2021.

Best performing analysts who are covering OMIC - Singular Genomics Systems:

Matthew Sykes Michael Ryskin John Sourbeer Tycho Peterson

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Nov-2022

$6.5

$22.5

2 years 4 months 14 days ago
(08-Jul-2024)

3/7 (42.86%)

$-1.15 (-15.03%)

73

Hold Since 06-Mar-2023

$15

$12

2 years 8 months 2 days ago
(20-Mar-2024)

2/8 (25%)

$-0.72 (-4.58%)

14

Buy Since 10-Aug-2022

$90

$630

4 years 3 months 12 days ago
(10-Aug-2022)

2/3 (66.67%)

$-13.2 (-12.79%)

6

Buy Since 21-Jun-2021

$750

$900.9

4 years 8 months 19 days ago
(03-Mar-2022)

0/2 (0%)

$520.5 (226.80%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OMIC (Singular Genomics Systems) average time for price targets to be met?

On average it took 23 days for the stock forecasts to be reached, with an average price target met ratio of 33.63%.

Which analyst most recently updated their price target on OMIC (Singular Genomics Systems)?

Matthew Sykes

Which analyst has the lowest performance score on OMIC (Singular Genomics Systems) with a proven track record?

TYCHO PETERSON

Which analyst has the most public recommendations on OMIC (Singular Genomics Systems)?

Matthew Sykes has 6 price targets and 5 ratings on OMIC

Which analyst is the currently most bullish on OMIC (Singular Genomics Systems)?

Tycho Peterson with the highest potential upside of $729.99

Which analyst is the currently most reserved on OMIC (Singular Genomics Systems)?

Matthew Sykes with the lowest potential downside of -$13.51
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?